Article

100 Day Vaccine Development–An Alternative Approach Boosters for Phase III Trialed Viral Family Vaccines

2023-12-06

Abstract excerpt

Researchers and organizations are pursing 100 Day Vaccine Development to reduce the impact of any new pandemic-causing virus. They propose monitoring viral emergence and developing vaccines for discovered viruses which would undergo safety testing in humans. If one of these viruses emerges, phase III trials would then take place. There are two problems with this approach - first, phase III trials are too long for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 279da3e0-b856-5e61-8fd7-65bdf08ebc6a
DOI: 10.20944/preprints202312.0408.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

100 Day Vaccine Development–An Alternative Approach Boosters for Phase III Trialed Viral Family VaccinesDOI 10.20944/preprints202312.0408.v1Read

Development of Novel VaccinesSemantic proximity Read

The Influenza Vaccine Mess.Semantic proximity Read

Characterising the benefits and risks of vaccines approved through accelerated pathwaysSemantic proximity Read

Highly Pathogenic Avian Influenza Vaccines: challenges for innovation, technological development and pandemic preparednessSemantic proximity Read

The Yellow Fever Vaccine Journey: Milestones and Future DirectionsSemantic proximity Read

Genetic and Phenotypic Characterization of Manufacturing Seeds for a Tetravalent Dengue Vaccine (DENVax)Semantic proximity Read

The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platformSemantic proximity Read

A Harmless Avian Vaccine Virus Could Be Developed into an Off-the-Shelf “Antibiotic” for VirusesSemantic proximity Read

Reversion to virulence of a subtype B avian metapneumovirus vaccine: Is it time for regulators to require availability of vaccine progenitors?Semantic proximity Read

Advancements in the development of subunit influenza vaccinesSemantic proximity Read

Live flavivirus vaccines: reasons for cautionSemantic proximity Read

Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMASemantic proximity Read